Tag: $Cidara Therapeutics

Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics

Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental drug for flu prevention in its effort to diversify ahead of patent loss for its blockbuster cancer drug Keytruda.